Hypersensitivity. Not indicated for dementia-related psychosis w/o symptoms of AAD; as an as-needed treatment for AAD. Discontinue use if NMS occurs & ANC <1,000/mm
3. Suicidal risk, thoughts & behaviours; tardive dyskinesia; metabolic changes including hyperglycemia, DM, dyslipidemia & wt gain; elevated prolactin levels; rare cases of priapism; VTE; leukopenia, neutropenia & agranulocytosis; orthostatic hypotension & syncope; QT prolongation; falls; seizures; body temp regulation; pathological gambling & other compulsive behaviours. Patients w/ known CV & cerebrovascular disease, conditions predisposing patients to hypotension or HTN; at risk of aspiration pneumonia; history or at risk of sleep apnea. Not to be taken by patients w/ galactose intolerance, total lactase deficiency or glucose-galactose malabsorption. May affect ability to drive & use machines. Hepatic & renal impairment. Pregnancy & lactation. Ped patients. Elderly patients w/ dementia-related psychosis.
Sign Out
